Related Experiment Video
Updated: Aug 15, 2026

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
Published on: February 7, 2025
Deaths following methotrexate overdoses by medical staff
Inga Sinicina1, Barbara Mayr, Gita Mall
1Institute of Legal Medicine, Ludwig-Maximilians-University Munich, Frauenlobstrasse 7A, D-80337 Munich, Germany. inga.sinicina@med.uni-muenchen.de
Abstract:
Methotrexate (MTX) is an effective disease modifying antirheumatic drug (DMARD) with a relatively safe profile, and it is widely used to treat neoplastic diseases and dermatologic and rheumatologic disorders. As indications for use of MTX increase, more accidental overdoses are noted to occur. Typical problems include deficiencies in labeling, instructions, or packaging, as well as erroneous use. We describe 5 fatal cases of repeated oral overdose of MTX prescribed by physicians in the treatment of rheumatoid arthritis to focus attention on the design of the underlying system and the organizational practices as sources of problems.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies
Drug Toxicity: Risk factors
Toxidromes: Clinical Features
Drug Toxicity: Overview